Literature DB >> 29265365

Defective trafficking of Kv2.1 channels in MPTP-induced nigrostriatal degeneration.

Ru-Yi Chao1, Chia-Hui Cheng1, Sheng-Nan Wu1,2, Pei-Chun Chen1,2.   

Abstract

Intracellular protein trafficking is tightly regulated, and improper trafficking might be the fundamental provocateur for human diseases including neurodegeneration. In neurons, protein trafficking to and from the plasma membrane affects synaptic plasticity. Voltage-gated potassium channel 2.1 (Kv2.1) is a predominant delayed rectifier potassium (K+ ) current, and electrical activity patterns of dopamine (DA) neurons within the substantia nigra are generated and modulated by the orchestrated function of different ion channels. The pathological hallmark of Parkinson's disease (PD) is the progressive loss of these DA neurons, resulting in the degeneration of striatal dopaminergic terminals. However, whether trafficking of Kv2.1 channels contributes to PD remains unclear. In this study, we demonstrated that MPTP/MPP+ increases the surface expression of the Kv2.1 channel and causes nigrostriatal degeneration by using a subchronic MPTP mouse model. The inhibition of the Kv2.1 channel by using a specific blocker, guangxitoxin-1E, protected nigrostriatal projections against MPTP/MPP+ insult and thus facilitated the recovery of motor coordination. These findings highlight the importance of trafficking of Kv2.1 channels in the pathogenesis of PD.
© 2017 International Society for Neurochemistry.

Entities:  

Keywords:  Kv2.1; Parkinson's disease; degeneration; protein trafficking

Mesh:

Substances:

Year:  2018        PMID: 29265365     DOI: 10.1111/jnc.14282

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  5 in total

1.  Clustered Kv2.1 decreases dopamine transporter activity and internalization.

Authors:  Joseph J Lebowitz; Jose A Pino; Phillip M Mackie; Min Lin; Cheyenne Hurst; Keeley Divita; Anthony T Collins; Dimitri N Koutzoumis; Gonzalo E Torres; Habibeh Khoshbouei
Journal:  J Biol Chem       Date:  2019-03-01       Impact factor: 5.157

2.  Defining the Kv2.1-syntaxin molecular interaction identifies a first-in-class small molecule neuroprotectant.

Authors:  Chung-Yang Yeh; Zhaofeng Ye; Aubin Moutal; Shivani Gaur; Amanda M Henton; Stylianos Kouvaros; Jami L Saloman; Karen A Hartnett-Scott; Thanos Tzounopoulos; Rajesh Khanna; Elias Aizenman; Carlos J Camacho
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-15       Impact factor: 11.205

3.  Genetic Knockout of TRPM2 Increases Neuronal Excitability of Hippocampal Neurons by Inhibiting Kv7 Channel in Epilepsy.

Authors:  Yingchao Ying; Lifen Gong; Xiaohan Tao; Junchao Ding; Nannan Chen; Yinping Yao; Jiajing Liu; Chen Chen; Tao Zhu; Peifang Jiang
Journal:  Mol Neurobiol       Date:  2022-09-02       Impact factor: 5.682

4.  Molecular Neuroprotection Induced by Zinc-Dependent Expression of Hepatitis C-Derived Protein NS5A Targeting Kv2.1 Potassium Channels.

Authors:  Jason A Justice; Daniel T Manjooran; Chung-Yang Yeh; Karen A Hartnett-Scott; Anthony J Schulien; Gabrielle J Kosobucki; Shalom Mammen; Michael J Palladino; Elias Aizenman
Journal:  J Pharmacol Exp Ther       Date:  2018-09-06       Impact factor: 4.030

5.  Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson's disease.

Authors:  Mikhail V Voronin; Ilya A Kadnikov; Dmitry N Voronkov; Sergey B Seredenin
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.